Indian Journal of Thoracic and Cardiovascular Surgery最新文献

{"title":"Evaluation of the effect of empagliflozin on prevention of atrial fibrillation after heart valve surgery: a double-blind, randomized, placebo-controlled trial.","authors":"Mahdi YazdFazeli, Sahar Samimi, Mohammad Abbasi Teshnizi, Hamid Hoseinikhah, Aliasghar Moeinipour, Omid Javedanfar, Vahid Ghavami, Farshad Abedi, Shahram Amini, Benyamin Fazli, Amir Hooshang Mohammadpour","doi":"10.1007/s12055-026-02240-6","DOIUrl":"10.1007/s12055-026-02240-6","url":null,"abstract":"<p><strong>Background: </strong>Postoperative atrial fibrillation (POAF) commonly complicates heart valve surgery. Empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, may offer antiarrhythmic benefits. This trial evaluated its efficacy in preventing POAF.</p><p><strong>Methods: </strong>In a double-blind placebo-controlled trial, 110 patients undergoing elective heart valve surgery were randomized to oral empagliflozin 10 mg daily (<i>n</i> = 55) or placebo (<i>n</i> = 55) from 3 days pre-op to 3 days post-op. All patients received standard care. The primary analysis was performed in a modified intention-to-treat (mITT) population, defined as randomized patients with at least one assessable primary outcome measurement; 81 patients were included in the final mITT analysis. The primary outcome was POAF incidence within 72 h, assessed via continuous electrocardiography (ECG) monitoring. Secondary outcomes included other arrhythmias, C-reactive protein (CRP) levels, and glycemic control.</p><p><strong>Results: </strong>POAF occurred in 8 patients (20.0%) in the empagliflozin group and 16 patients (39.0%) in the placebo group, corresponding to a 49% relative risk reduction, although this difference did not reach statistical significance (<i>p</i> = 0.088). Empagliflozin was associated with non-significant reductions in ventricular tachycardia (2.5% vs. 14.6%, <i>p</i> = 0.109) and premature ventricular contractions (45.0% vs. 65.9%, <i>p</i> = 0.075). Postoperative blood glucose levels were significantly lower in the empagliflozin group on days 1 and 2 (<i>p</i> < 0.05). No significant differences were observed in postoperative CRP levels (<i>p</i> = 0.12) or adverse event rates, including hypoglycemia and infection.</p><p><strong>Conclusion: </strong>Short-term perioperative empagliflozin did not significantly reduce the incidence of POAF after heart valve surgery; however, the results suggest a possible reduction in POAF and improved postoperative glycemic control, without an apparent increase in adverse events in this selected, closely monitored population. These findings require confirmation in larger randomized trials.</p><p><strong>Graphical abstract: </strong></p>","PeriodicalId":13285,"journal":{"name":"Indian Journal of Thoracic and Cardiovascular Surgery","volume":"42 9","pages":"1023-1033"},"PeriodicalIF":0.6,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13437836/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148678516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Temporary femoro-femoral external shunt for lower-extremity malperfusion in acute type A aortic dissection.","authors":"Ryoi Okano, Dai Kawashima, Satoru Maeba","doi":"10.1007/s12055-026-02208-6","DOIUrl":"10.1007/s12055-026-02208-6","url":null,"abstract":"<p><p>Acute limb ischemia is a severe complication of acute type A aortic dissection (ATAAD). The optimal management strategy remains debated and is dependent on the clinical context. Herein, we report the case of a 58-year-old man with ATAAD complicated by right lower limb malperfusion. During the aortic root replacement, regional oxygen saturation (rSO2) of the lower extremities was monitored using near-infrared spectroscopy, which demonstrated an early decline in right limb rSO2. To achieve prompt reperfusion, a femoro-femoral external shunt from the left to the right common femoral artery was established, serving as a bridge for definitive femoro-femoral bypass. The postoperative course was uneventful, without any evidence of reperfusion syndrome or neurological deficits. Thus, in certain cases, an external shunt may provide an effective bridging strategy for limb ischemia, and a decrease in rSO2 may serve as an early indicator for immediate reperfusion.</p>","PeriodicalId":13285,"journal":{"name":"Indian Journal of Thoracic and Cardiovascular Surgery","volume":"42 9","pages":"1093-1097"},"PeriodicalIF":0.6,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13438137/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148678547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Valve-sparing surgery for right-sided endocarditis presenting as a giant right atrial mass in a hemodialysis patient.","authors":"David Bellido-Yarlequé, Roberto Baltodano-Arellano, Rossi Ramos-Isidro, Kevin Velarde-Acosta, Georgette Vetanzo-Sánchez, Jean Pool Cabello-Barron","doi":"10.1007/s12055-026-02203-x","DOIUrl":"10.1007/s12055-026-02203-x","url":null,"abstract":"<p><p>Tricuspid valve infective endocarditis (TVIE) is an uncommon form of right-sided endocarditis, typically associated with intravenous drug use or intravascular devices. Diagnosis is often delayed in immunocompromised patients, particularly those undergoing chronic hemodialysis (HD). We describe a 51-year-old woman with systemic lupus erythematosus (SLE), diabetes, and end-stage renal disease (ESRD) on chronic HD via a tunneled central venous catheter (TCVC). She presented with generalized weakness, hypotensive episodes during HD, and persistent fever. Blood cultures grew <i>Staphylococcus aureus</i>, and chest computed tomography (CT) revealed bilateral cavitary nodules consistent with septic pulmonary emboli. Transesophageal echocardiography (TEE) identified a 5 × 2.3-cm mobile and digitiform vegetation attached to the tricuspid valve, extending into the right atrium and superior vena cava (SVC). Despite targeted antibiotics, the infection persisted. Intraoperative findings revealed a 7-cm fibrous mass with a 3-cm calcified base adherent to the tricuspid valve, extending into the right atrium and causing near-total occlusion of the SVC. The mass was excised, and the native valve was successfully preserved. The postoperative course was uneventful. This case highlights the diagnostic and therapeutic complexity of TVIE in immunosuppressed dialysis patients. Surgical intervention was indicated due to persistent bacteremia, embolic complications, and large vegetations, in line with current European Society of Cardiology (ESC) guidelines. Notably, the native valve was preserved despite extensive intracardiac involvement, representing a favorable surgical outcome. Clinicians should maintain a high index of suspicion for right-sided endocarditis in dialysis patients presenting with respiratory or embolic symptoms.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s12055-026-02203-x.</p>","PeriodicalId":13285,"journal":{"name":"Indian Journal of Thoracic and Cardiovascular Surgery","volume":"42 9","pages":"1089-1092"},"PeriodicalIF":0.6,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13437840/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148678591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Successful repair of a rare submitral aneurysm with basal septal defect: a technique combining edge-to-edge repair and patch exclusion.","authors":"Gaurish Sawant, Balaji Aironi, Ayush Agarwal, Aishwarya Purohit, Rajat Lohiya, Hitesh Makhija","doi":"10.1007/s12055-026-02212-w","DOIUrl":"10.1007/s12055-026-02212-w","url":null,"abstract":"<p><p>Submitral left ventricular aneurysm (SLVA) is an exceedingly rare clinical entity associated with high mortality due to potential rupture, systemic embolism, and severe mitral regurgitation (MR). Surgical management is complex, necessitating strategies that address both the aneurysm and the valvular pathology while preserving ventricular geometry. We present the case of a 44-year-old male presenting with syncope and acute heart failure. Multi-modality imaging, including cardiac magnetic resonance imaging (MRI), revealed a large (7.4 × 6.9 cm) basal septal left ventricle (LV) aneurysm with a thick mural thrombus and severe MR secondary to anterior leaflet tethering. Coronary angiography ruled out ischemic etiology. Under cardiopulmonary bypass, the mitral valve was accessed via a paraseptal left atrial approach. An Alfieri stitch (edge-to-edge repair) was utilized to correct the leaflet prolapse, achieving competent coaptation. The aneurysm was approached externally; the cavity was incised, and the thrombus evacuated. The 2.5-cm aneurysmal neck was excluded using an autologous pericardial patch, followed by a double-layer linear aneurysmorrhaphy to obliterate the cavity. The patient had an uneventful postoperative course and was discharged on day 9. This case demonstrates that a combined approach-aneurysm exclusion via pericardial patch and concomitant edge-to-edge mitral valve repair-provides a durable, safe solution for SLVA. This strategy effectively eliminates the embolic source and restores valvular competence without compromising left ventricular function.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s12055-026-02212-w.</p>","PeriodicalId":13285,"journal":{"name":"Indian Journal of Thoracic and Cardiovascular Surgery","volume":"42 9","pages":"1098-1102"},"PeriodicalIF":0.6,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13438043/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148678583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Transcatheter versus surgical aortic valve replacement for severe aortic stenosis in low-risk adults: a network meta-analysis.","authors":"Kanandya Kizzandy, Yehezkiel Gian Pradipta Pahu, Satria Rafi Ratmandhika, Krisanto Tanjaya, Elsafira Rana Rinanada, Muhammad Yusuf, Muhammad Reva Aditya, Imam Suseno Bayuadi","doi":"10.1007/s12055-026-02245-1","DOIUrl":"10.1007/s12055-026-02245-1","url":null,"abstract":"<p><strong>Purpose: </strong>To compare the safety and efficacy of transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR) in low-risk severe aortic stenosis, and to assess the differential impact of balloon-expandable (BE) and self-expanding (SE) valve platforms on clinical outcomes.</p><p><strong>Methods: </strong>A systematic search across seven databases was performed through May 2024. Frequentist and Bayesian network meta-analyses were conducted across three pre-specified time horizons: 30 days, 1 to 2 years, and 3 or more years. Results are reported as odds ratios (OR) with 95% confidence intervals (CI). Egger's regression testing and randomized controlled trial (RCT)-only sensitivity analyses were performed.</p><p><strong>Results: </strong>Thirty-one studies (37,741 patients) were included. All TAVR types demonstrated comparable short-term and intermediate-term mortality to SAVR, with TAVR-BE ranking most favourably by Surface Under the Cumulative Ranking (SUCRA) (81.2% and 87.7%); these rankings should be interpreted alongside the non-significant effect estimates. In exploratory ≥3-year analyses (k=10 studies, consistent with RCT-only sensitivity analyses), TAVR-Mixed showed significantly higher mortality than SAVR (OR 1.963 [95% CI 1.620 to 2.378]; p<0.001), while TAVR-BE and TAVR-SE showed no significant difference. TAVR-BE significantly reduced 30-day rehospitalization (OR 0.625; p=0.007), stroke (OR 0.534; p=0.001), atrial fibrillation, acute kidney injury, and major bleeding versus SAVR. All TAVR platforms shortened hospital stay by approximately 4 days. SAVR was associated with significantly lower rates of paravalvular regurgitation and permanent pacemaker implantation at all time horizons.</p><p><strong>Conclusion: </strong>In low-risk severe aortic stenosis, TAVR, particularly with balloon-expandable valves, appears to offer comparable short-term and intermediate-term survival with superior procedural safety versus SAVR. In exploratory ≥3-year analyses, SAVR was associated with lower mortality specifically within the heterogeneous TAVR-Mixed cohort; TAVR-BE and TAVR-SE showed no significant mortality difference from SAVR at this horizon, underscoring the importance of platform-specific and individualised decision-making.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s12055-026-02245-1.</p>","PeriodicalId":13285,"journal":{"name":"Indian Journal of Thoracic and Cardiovascular Surgery","volume":"42 9","pages":"1066-1088"},"PeriodicalIF":0.6,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13437856/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148678530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"AI can write the paper-but whose paper is it?","authors":"Pradeep Narayan","doi":"10.1007/s12055-026-02262-0","DOIUrl":"10.1007/s12055-026-02262-0","url":null,"abstract":"","PeriodicalId":13285,"journal":{"name":"Indian Journal of Thoracic and Cardiovascular Surgery","volume":"42 9","pages":"1021-1022"},"PeriodicalIF":0.6,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13437816/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148678298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Resurfacing of awake coronary artery bypass grafting with mid thoracic epidural anesthesia technique.","authors":"Priyanka T Nagarajaiah, Sudhakar Koneru, Thota Venkata Sanjeev Gopal, N Nageswara Rao","doi":"10.1007/s12055-026-02209-5","DOIUrl":"10.1007/s12055-026-02209-5","url":null,"abstract":"<p><p>Awake coronary artery bypass grafting (CABG) is increasingly becoming recognized as a feasible alternative for high-risk cardiac patients, with a potential to reduce perioperative morbidity. In light of this, high thoracic epidural anesthesia (HTEA) has been used for cardiac surgery over the past two decades, providing excellent analgesia and sympathetic blockade. In this case report, a 71-year-old patient with interstitial lung disease (ILD) on home oxygen treatment had successful awake CABG at our institute, using a combined mid-thoracic and lumbar epidural approach. This method offered effective segmental anesthesia and analgesia, ensuring patient comfort and hemodynamic stability throughout the surgery. In comparison to HTEA, the mid-thoracic epidural approach provided better control of anesthesia and analgesia, minimized the risk of high sympathetic blockade, and facilitated early postoperative recovery with minimum opioid usage and early mobilization without any intraoperative or postoperative complications. This case emphasizes the feasibility and potential advantages of combined mid-thoracic and lumbar epidural anesthesia over high thoracic epidural in selected high-risk patients undergoing awake CABG.</p>","PeriodicalId":13285,"journal":{"name":"Indian Journal of Thoracic and Cardiovascular Surgery","volume":"42 9","pages":"1103-1106"},"PeriodicalIF":0.6,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13438054/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148678440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Outcomes of minimally invasive mitral valve repair for non-rheumatic mitral regurgitation: an 8-year retrospective analysis.","authors":"Rajesh M Ramankutty, Jecco Ani Babu, Aiswarya Mohan","doi":"10.1007/s12055-026-02213-9","DOIUrl":"10.1007/s12055-026-02213-9","url":null,"abstract":"<p><strong>Purpose: </strong>Minimally invasive mitral valve repair (MIMVR) offers several advantages over sternotomy, including reduced surgical trauma and faster recovery. However, the quality of repair and long-term functional outcomes have been debated due to the limited access involved. This study evaluates the success of repair, various methods used, functional outcomes, survival rates, and re-intervention rates in patients undergoing MIMVR at Caritas Hospital, Kerala, from 2016 to 2023.</p><p><strong>Methods: </strong>A retrospective cohort study of 114 patients who underwent MIMVR via right mini-thoracotomy was conducted. The techniques included triangular resection, posterior annuloplasty ring, neochords reconstruction, leaflet resection, foldoplasty, and Alfieri stitch. Transoesophageal echocardiography (TOE), intraoperative saline injection test, and on-pump antegrade cardioplegia were used to assess repair integrity. Patients were followed up at 1, 3, and 12 months post-discharge, and annually thereafter. The primary endpoints were survival and recurrent mitral regurgitation (MR), with secondary endpoints being periprocedural complications and freedom from reoperation.</p><p><strong>Results: </strong>The mean follow-up period was 5 years, with an 87% freedom from moderate or severe MR. The perioperative characteristics included a mean age of 52.13 ± 13.11 years, with 72.8% male. The average cardiopulmonary bypass (CPB) and aortic cross-clamp times were 178.78 ± 33.85 and 128.58 ± 27.61 min, respectively. No conversions to sternotomy were required. Postoperative outcomes showed no significant SAM or severe MR, with a stroke incidence of 1.75%. At 1 year, 86.8% of patients were asymptomatic, with 12.3% having moderate or greater MR.</p><p><strong>Conclusion: </strong>MIMVR can achieve high-quality functional outcomes without compromising durability and is associated with low postoperative morbidity. The study supports MIMVR as a viable alternative to conventional approaches, providing favourable safety and results in treating MR. The technique has been particularly effective in patients with degenerative disease, including myxomatous and Barlow's disease, making it a preferred method at our institution.</p><p><strong>Graphical abstract: </strong></p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s12055-026-02213-9.</p>","PeriodicalId":13285,"journal":{"name":"Indian Journal of Thoracic and Cardiovascular Surgery","volume":"42 9","pages":"1034-1044"},"PeriodicalIF":0.6,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13437871/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148678512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Systemic inflammatory response and complications developing in patients undergoing lobectomy for non-small-cell lung cancer: thoracotomy versus video-assisted thoracoscopic surgery.","authors":"Gizem Kececi Ozgur, Hasan Yavuz, Ahmet Kayahan Tekneci, Kevser Durgun, Tevfik Ilker Akcam, Ayse Gul Ergonul, Kutsal Turhan, Alpaslan Cakan, Ufuk Cagirici","doi":"10.1007/s12055-026-02228-2","DOIUrl":"10.1007/s12055-026-02228-2","url":null,"abstract":"<p><strong>Purpose: </strong>The present study investigates the effect of different surgical approaches on the systemic inflammatory response and the development of complications in patients undergoing lobectomy for non-small-cell lung cancer.</p><p><strong>Methods: </strong>The data of 223 patients who underwent lobectomy for non-small-cell lung cancer via either thoracotomy or video-assisted thoracoscopic surgery (VATS) between 2015 and 2023 were analyzed retrospectively. Neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), and pan-immune-inflammation value (PIV) were used to assess inflammatory response.</p><p><strong>Results: </strong>Of the patients included in the study, 39 (17.5%) were female and 184 (82.5%) were male, and mean age was 63.46 (standard deviation (SD) 10.24) years (min 18-max 84). Of the sample, 59 (26.5%) underwent lobectomy via VATS and 164 (73.5%) via thoracotomy. Delta NLR, delta SII, and delta PIV were all found to be higher in the thoracotomy group than in the VATS group (<i>p</i> < 0.001, <i>p</i> < 0.001, <i>p</i> = 0.002, respectively). In a univariate analysis examining development of complications, delta NLR and delta SII were significantly higher in the group with complications (<i>p</i> = 0.020, <i>p</i> = 0.026, respectively), while no significant difference was observed in delta PIV (<i>p</i> = 0.066). In multivariable linear regression models adjusted for age, gender, presence of comorbidity, tumor location, tumor size, lymph node involvement, tumor stage, and surgical method, thoracotomy was associated with a greater increase in delta NLR (<i>p</i> = 0.016), as well as approximately 71% and 84% greater increases in delta SII and delta PIV, respectively (<i>p</i> = 0.013 and <i>p</i> = 0.003).</p><p><strong>Conclusion: </strong>The present study revealed that patients who underwent lobectomy via VATS for non-small-cell lung cancer had a lower systemic inflammatory response than those undergoing lobectomy via thoracotomy. The increase in inflammatory markers, including NLR, SII, and PIV, was more remarkable in patients undergoing thoracotomy.</p>","PeriodicalId":13285,"journal":{"name":"Indian Journal of Thoracic and Cardiovascular Surgery","volume":"42 9","pages":"1045-1052"},"PeriodicalIF":0.6,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13437817/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148678616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Correction to: Surgery for hypertrophic obstructive cardiomyopathy: the European perspective.","authors":"Eduard Quintana, Polina Danchenko, Kostiantyn Rudenko, Sertaç Cicek, Alex Shipolini, Jerry Braun, Christophe Baufreton, Patrick O Myers, Gloria Färber, Julia Dumfarth, Sara Ranchordás, Gvido Varpins, Peteris Stradins, Lucian Dorobantu, Maciej Kolowca, Ruggero De Paulis, Kamran K Musayev, Ehud Raanani, Shahab Nozohoor, Daniel Pereda, Carlos Alberto Mestres","doi":"10.1007/s12055-026-02248-y","DOIUrl":"https://doi.org/10.1007/s12055-026-02248-y","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1007/s12055-025-02147-8.].</p>","PeriodicalId":13285,"journal":{"name":"Indian Journal of Thoracic and Cardiovascular Surgery","volume":"42 9","pages":"1111"},"PeriodicalIF":0.6,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13438087/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148678328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}